TAUNS Laboratories,Inc. (TYO:197A)

Revenue by Segment

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
IVD (In Vitro Diagnostics) Business	14.37B	18.63B	18.43B	15.67B
Total	14.37B	18.63B	18.43B	15.67B

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error